Global Liver Institute has consistently advocated for a more muscular and proactive set of solutions for transplant recipients, cancer patients, and individuals with compromised immune systems...
(Washington, D.C., Monday, July 26, 2021)—Global Liver Institute (GLI) today urged the U.S. Food and Drug Administration to expedite the review of growing safety and effectiveness data and approve...
(Washington, D.C., Thursday, July 15, 2021)—Global Liver Institute (GLI) is urging the U.S. Office of Management and Budget (OMB) to implement fixes to the organ transplantation system rife with...
(Washington, D.C., Wednesday, July 7, 2021)—Global Liver Institute (GLI) today announced the hiring of Robert Mitchell-Thain, a prominent international patient advocate, to the newly created...
POLICY PERSPECTIVE As a patient advocacy organization committed to improving the lives of all transplant recipients, Global Liver Institute (GLI) appreciates the continued leadership of medical...
(Washington. D.C., Thursday, June 10, 2021)—Global Liver Institute (GLI), the worldwide leader in liver health advocacy, is pleased to announce a partnership with NutriStyle Inc. to...
WASHINGTON, D.C.—Global Liver Institute (GLI) is convening the fourth International NASH Day on June 10, 2021, at 2 a.m. Eastern, United States. Eight virtual panels of international experts will...
(Washington, D.C., Thursday, May 27, 2021)—Global Liver Institute (GLI) today formally announced its Liver Action Network, a national U.S. initiative to connect liver patients, caregivers, and...
WASHINGTON, D.C.—Global Liver Institute (GLI) will convene the fourth International NASH Day on June 10, 2021. Eight virtual panels of international experts will shed light on nonalcoholic...
As COVID-19 vaccines roll out, more and more schools and workplaces are inching toward fully reopening for in-person work or instruction. While the mental health challenges of being disconnected...
Recent News
Understanding the New EASL-EASD-EASO Guidelines on MASLD New Clinical Practice Guidelines for MASLD, developed jointly by EASL, EASD, and EASO, update the 2016 guidelines to reflect recent advancements. They focus on early identification and intervention and the...
Global Liver Institute Welcomes Larry R. Holden as CEO(Washington, D.C., September 3, 2024) – The Board of Directors of Global Liver Institute (GLI), the premier liver patient advocacy organization, has appointed Larry R. Holden as the organization’s Chief Executive...
More Than a Cure, a Path to Improvement: Hepatitis C TreatmentHepatitis C infection, an infection of the liver by the hepatitis C virus, is a major global health concern, affecting millions. Although the liver itself does not have pain receptors, the inflammation due...
Understanding the New EASL-EASD-EASO Guidelines on MASLDWho are EASL, EASD, EASO? EASL, EASD, and EASO are prominent European organizations in the field of health and medicine, each focusing on a specific area: The European Association for the Study of the Liver...
GLI Celebrates FDA Approval of Livdelzi®, an Option in Personalizing PBC Treatment (Washington, D.C. August 14, 2024) – Global Liver Institute (GLI) celebrates the expansion of treatment options for patients with primary biliary cholangitis (PBC) after the U.S. Food...
